GetTopicDetailResponse(id=adf8929321e, topicName=超進展, introduction=超進展, content=null, image=null, comments=5, allHits=887, url=https://h5.medsci.cn/topic?id=92932, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=80485, tagList=[TagDto(tagId=80485, tagName=超進展)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1813563, encodeId=e8351813563fa, content=<a href='/topic/show?id=adf8929321e' target=_blank style='color:#2F92EE;'>#超進展#</a>, objectTitle=JAMA Oncol ：晚期非小細胞肺癌NSCLC免疫治療中的超進展, objectType=article, longId=198672, objectId=a2c81986e2fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c81986e2fe, replyNumber=0, likeNumber=114, createdTime=2020-08-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c81986e2fe, moduleTitle=JAMA Oncol ：晚期非小細胞肺癌NSCLC免疫治療中的超進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a2c81986e2fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813562, encodeId=94581813562dd, content=<a href='/topic/show?id=adf8929321e' target=_blank style='color:#2F92EE;'>#超進展#</a>, objectTitle=WCLC 2019搶先看∣作為當(dāng)前探討的熱點，免疫治療超進展又有哪些新近進展？, objectType=article, longId=178772, objectId=c6911e877262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6911e877262, replyNumber=0, likeNumber=98, createdTime=2020-05-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6911e877262, moduleTitle=WCLC 2019搶先看∣作為當(dāng)前探討的熱點，免疫治療超進展又有哪些新近進展？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c6911e877262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813561, encodeId=671a1813561c5, content=<a href='/topic/show?id=adf8929321e' target=_blank style='color:#2F92EE;'>#超進展#</a>, objectTitle=PNAS：破解PD-1抗體促進癌癥超進展之謎！日本科學(xué)家發(fā)現(xiàn)PD-1抗體可激活調(diào)節(jié)T細胞，導(dǎo)致癌癥超進展, objectType=article, longId=165899, objectId=551416589938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=551416589938, replyNumber=0, likeNumber=97, createdTime=2019-07-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=551416589938, moduleTitle=PNAS：破解PD-1抗體促進癌癥超進展之謎！日本科學(xué)家發(fā)現(xiàn)PD-1抗體可激活調(diào)節(jié)T細胞，導(dǎo)致癌癥超進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=551416589938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813560, encodeId=2c901813560bf, content=<a href='/topic/show?id=adf8929321e' target=_blank style='color:#2F92EE;'>#超進展#</a>, objectTitle=JAMA Oncol：迄今為止大規(guī)模免疫“超進展”研究，你想知道的都在這里！, objectType=article, longId=158015, objectId=97ba15801539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ba15801539, replyNumber=0, likeNumber=95, createdTime=2019-04-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ba15801539, moduleTitle=JAMA Oncol：迄今為止大規(guī)模免疫“超進展”研究，你想知道的都在這里！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=97ba15801539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813559, encodeId=3e2118135598d, content=<a href='/topic/show?id=adf8929321e' target=_blank style='color:#2F92EE;'>#超進展#</a>, objectTitle=JAMA Oncol：基線合并多個轉(zhuǎn)移灶的NSCLC，更易出現(xiàn)免疫治療超進展, objectType=article, longId=149016, objectId=1e5b1490168d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e5b1490168d, replyNumber=0, likeNumber=93, createdTime=2019-05-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e5b1490168d, moduleTitle=JAMA Oncol：基線合并多個轉(zhuǎn)移灶的NSCLC，更易出現(xiàn)免疫治療超進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1e5b1490168d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
